C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
12/2001
12/05/2001	EP1158993A1 Bacterial membrane fractions with adjuvant effect
12/05/2001	EP1054660B1 Cosmetic composition containing a compound with activity stimulating interleukin-6
12/05/2001	EP0831695B1 Bacteria having nematicidal activity and their agricultural use
12/05/2001	EP0769056B1 NON-SPLICING VARIANTS OF gp350/220
12/05/2001	EP0663955B1 Nucleic acid coding for an alpha-acetolactate decarboxylase and applications
12/05/2001	EP0663953B1 Phagemids coexpressing a surface receptor and a surface heterologous protein
12/05/2001	EP0651809B1 A family of map2 protein kinases
12/05/2001	CN1325453A Vancoresmycin, a process for its production and its use as a pharmaceutical
12/05/2001	CN1325449A Nucleic acid molecules which code a branching enzyme from bacteria of the Genus Neisseria, and a method for producing alpha-1,6-branched alpha-1,4-glucans
12/05/2001	CN1325447A Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
12/05/2001	CN1325445A Method for generating a gene library
12/05/2001	CN1325444A Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism
12/05/2001	CN1325443A Glycosylated proteins having reduced allergenicity
12/05/2001	CN1325442A Endothelial cell proliferation inhibitors derived from human prothrombin
12/05/2001	CN1325407A Platelet-derived growth factor D, DNA coding therefor and uses thereof
12/05/2001	CN1325404A Low allergenic proteinvariants
12/05/2001	CN1324882A Purified PH-neutral rhizoctonia laccase and nucleic acid for coding said laccase
12/05/2001	CN1075836C Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
12/04/2001	US6326477 Nucleotide sequences coding polypeptide which maintains viability in genetically engineeered fungus; for use as a tool in controlled gene expression
12/04/2001	US6326462 Polypeptides exhibits lumazine synthase
12/04/2001	US6326357 Bacterial cell complex composition and method of use
12/04/2001	US6326351 Insecticides
12/04/2001	US6326350 Genetic engineering
12/04/2001	US6326211 Method of manipulating a gas bubble in a microfluidic device
12/04/2001	US6326207 Human sodium-dependent phosphate cotransporter
12/04/2001	US6326185 Method for decontaminating yeast
12/04/2001	US6326184 Method of producing a composite fermented beverage using genetically modified yeast strains
12/04/2001	US6326170 Prokaryotic polynucleotides, polypeptides and their uses
12/04/2001	US6326169 Nucleotide sequences coding insecticidal protein for use in biological pest control
12/04/2001	US6326168 Membrane polypeptides for use in the treatment of nervous system disorders, epilepsy and brain disorders
12/04/2001	US6326165 Nucleotide sequences used for the detection of preferential basic helix loop helix genes; for detection of insectcide tolerant genes
12/04/2001	US6326164 Contacting pyruvate and optionally, glyceraldehyde 3-phosphate, with polypeptide and determining the concentration of pyruvate and/or glyceradehyde 3-phosphate remaining
12/04/2001	US6326162 Assays and peptide substrate for determining aggrecan degrading metallo protease activity
12/04/2001	US6326151 Screening methods to identify agents that selectively inhibit hepatitis C virus replication
12/04/2001	US6326150 Yeast interaction trap assay
12/04/2001	US6326141 Detecting pancreatic defect; evaluate humans for preferential gene expression, compare to healty human, amplified expression from preferential gene indicates pancreatic defect
12/04/2001	US6326037 Microorganisms and their use in treating animal feed and silage
12/04/2001	US6326016 Plant immunization compositions
12/04/2001	US6326008 Toxoplasma gondii antigens, the preparation thereof and the use thereof
12/04/2001	CA2189682C Process for producing trans-4-hydroxy-l-proline
12/04/2001	CA1341324C Esterase enzymes used in the process for the preparation of 2-arylpropionic acids
12/01/2001	CA2347276A1 I g e-dependent histamine-releasing factor (hrf) receptor, hrf-binding peptides and nucleic acids encoding the same, and uses thereof
11/2001
11/29/2001	WO2001090395A1 A method for manufacturing highly-concentrated polyglutamic acid with additional supply of saccharides
11/29/2001	WO2001090375A1 Endoglucanase nce5 and cellulase preparations containing the same
11/29/2001	WO2001090372A1 Lactobacillus reuteri glucosyltransferase
11/29/2001	WO2001090371A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001	WO2001090370A2 Method for microbial production of difructose anhydride iii, micro-organism used therefor and enzyme with inulase ii activity and dna sequences coding therefor
11/29/2001	WO2001090365A2 Human protein kinase '13305' and uses therefor
11/29/2001	WO2001090363A1 Chimeric arterivirus-like particles
11/29/2001	WO2001090360A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/29/2001	WO2001090359A2 G-protein coupled receptors
11/29/2001	WO2001090358A2 Mammalian receptor proteins; related reagents and methods
11/29/2001	WO2001090337A2 Detection of rna
11/29/2001	WO2001090334A2 Drug metabolizing enzymes
11/29/2001	WO2001090333A2 Recombinant bacterial phytases and uses thereof
11/29/2001	WO2001090330A2 AMINOACYL tRNA SYNTHETASES
11/29/2001	WO2001090328A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/29/2001	WO2001090317A2 Beta-galactosidase isolated from a bifidobacterium
11/29/2001	WO2001090312A1 Ammonia-oxidizing bacteria
11/29/2001	WO2001090311A1 Novel probiotics for pet food applications
11/29/2001	WO2001090310A1 PROCESS FOR PRODUCING η-GLUTAMYLCYSTEINE
11/29/2001	WO2001090306A2 Compositions and methods for modulating tumor specific expression
11/29/2001	WO2001090305A2 LACTOBACILLUSβ -GLUCURONIDASE AND DNA ENCODING THE SAME
11/29/2001	WO2001090304A2 Nucleic acids, proteins, and antibodies
11/29/2001	WO2001090189A2 G-protein coupled receptor org3.
11/29/2001	WO2001090188A2 Receptor-based interaction trap
11/29/2001	WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/29/2001	WO2001090152A2 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001	WO2001090151A2 Human receptor proteins; related reagents and methods
11/29/2001	WO2001090148A2 Neurotransmitter transporters
11/29/2001	WO2001090147A2 Long wavelength engineered fluorescent proteins
11/29/2001	WO2001090139A2 A ligand for enhancing oral and cns delivery of biological agents
11/29/2001	WO2001089568A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/29/2001	WO2001089541A1 Use of lactobacillus casei in immunostimulatory peptides
11/29/2001	WO2001089454A2 Proteus mirabilis-based vaccine
11/29/2001	WO2001089297A2 A bioinsecticide formulation consisting of bacillus thuringiensis var israelensis, and its concerning manufacture proceedings
11/29/2001	WO2001062284A3 Novel method for down-regulation of amyloid
11/29/2001	WO2001058935A3 FACTOR VII OR VIIa-LIKE MOLECULES
11/29/2001	WO2001055173A8 Nucleic acids, proteins, and antibodies
11/29/2001	WO2001044280A3 Methods and compositions for the manufacture of replication incompetent adenovirus
11/29/2001	WO2001042471A8 Polypeptides and polynucleotides encoding same
11/29/2001	WO2001042446A3 A functional gene array in yeast
11/29/2001	WO2001040451A3 Masp-3, a complement-fixing enzyme, and uses for it
11/29/2001	WO2001040309A3 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use
11/29/2001	WO2001040257A3 Modified il-12 subunits and nucleic acids encoding them
11/29/2001	WO2001038566A3 Screening method for candidate drugs
11/29/2001	WO2001036644A3 Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
11/29/2001	WO2001031007A3 Nucleic acid molecules derived from rat brain and programmed cell death models
11/29/2001	WO2001025433A3 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
11/29/2001	WO2001023590A3 22196, a novel human aminopeptidase
11/29/2001	WO2001016318A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/29/2001	WO2001000846A3 Linoleate isomerase
11/29/2001	WO2000075350A3 Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
11/29/2001	WO2000073469A3 Protein kinases
11/29/2001	WO2000040722A3 Insulin-synthesis genes
11/29/2001	US20010046972 Novel immuno-stimulating polysaccharide substance from phellinus spp. strain and use thereof
11/29/2001	US20010046707 Enhancing the competence of a cell through production of a library of recombinant genes
11/29/2001	US20010046698 Method capable of increasing competency of bacterial cell transformation
11/29/2001	US20010046697 Bacillus natto culture extract

1 ... 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 ... 1489